XPHARMA
ActiveSummary
XPHARMA has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €889,956 and a net result of €318,475. Equity is growing by about 75% per year across the filed financial years. Its solvency ranks better than 46% of 22,576 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
22-09
Gazette deed
Registered officeRegistered-office move2 facts ▸
- General meeting, 01-09-2023
- Registered-office move, Zavelstraat 14, 2870 Puurs-Sint-Amands
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.